Yale School of Medicine researchers report in Nature Genetics this week that they have identified a gene whose function protects the body against kidney stones.
The research identifies a transporter, encoded by the gene, as a potential target for drugs to boost oxalate secretion in the gut and help prevent kidney stones, said Peter Aronson, M.D., professor of internal medicine and physiology and senior author of the study.
The most common type of kidney stones are composed of calcium oxalate. The transporter, known as SLC26A6, normally secretes oxalate into the intestine and prevents absorption of too much of the oxalate from the diet.
"When this gene is knocked out in the mouse, more oxalate from the diet is absorbed, the plasma level of oxalate is increased, more oxalate is excreted in the urine by the kidney, and kidney stones are formed," Aronson said.
In addition to pinpointing a potential drug target, he said the research raises the possibility that abnormal expression or regulation of the anion transporter encoded by the gene could cause kidney stones in humans, although this has not yet been tested directly.
Page: 1 Related medicine news :1
Contact: Jacqueline Weaver
. Stanford researchers find culprit in aging muscles that heal poorly2
. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA3
. Penn researchers discover novel pathway for increasing good cholesterol4
. Theory of facial aging gets a facelift from UT Southwestern researchers5
. UIC researchers to develop new drugs to fight bioterrorism6
. UQ researchers discover some of the oldest forms of life7
. U of M researchers discover new method to combat HIV8
. U of M researchers assess effectiveness of computerized physician order entry system9
. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid10
. Physician-researchers often less successful in obtaining NIH funding11
. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells